Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

1-25 of 201 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

IL-2-free tumor-infiltrating lymphocyte therapy with PD-1 blockade demonstrates potent efficacy in advanced gynecologic cancer.
Guo J, Wang C, Luo N, Wu Y, Huang W, Zhu J, Shi W, Ding J, Ge Y, Liu C, Lu Z, Bast RC, Ai G, Yang W, Wang R, Li C, Chen R, Liu S, Jin H, [...] Cheng Z
BMC Med, 22(1):207, 20 May 2024
Cited by: 0 articles | PMID: 38769543 | PMCID: PMC11106999
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Mathematical modeling of endogenous and exogenously administered T cell recirculation in mouse and its application to pharmacokinetic studies of cell therapies.
Nikitich A, Helmlinger G, Peskov K, Bocharov G
Front Immunol, 15:1357706, 17 Apr 2024
Cited by: 0 articles | PMID: 38846946
Add to export list
How I treat cytopenias after CAR T-cell therapy.
Jain T, Olson TS, Locke FL
Blood, 141(20):2460-2469, 01 May 2023
Cited by: 37 articles | PMID: 36800563 | PMCID: PMC10646792
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Lymphopenia and Mechanisms of T-Cell Regeneration.
Saidakova EV
Cell tissue biol, 16(4):302-311, 08 Aug 2022
Cited by: 0 articles | PMID: 35967247 | PMCID: PMC9358362
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Clinical Strategies for Enhancing the Efficacy of CAR T-Cell Therapy for Hematological Malignancies.
Liu Q, Liu Z, Wan R, Huang W
Cancers (Basel), 14(18):4452, 14 Sep 2022
Cited by: 2 articles | PMID: 36139611 | PMCID: PMC9496667
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Agent-based computational modeling of glioblastoma predicts that stromal density is central to oncolytic virus efficacy.
Jenner AL, Smalley M, Goldman D, Goins WF, Cobbs CS, Puchalski RB, Chiocca EA, Lawler S, Macklin P, Goldman A, Craig M
iScience, 25(6):104395, 13 May 2022
Cited by: 17 articles | PMID: 35637733 | PMCID: PMC9142563
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
PD-1 blockade therapy augments the antitumor effects of lymphodepletion and adoptive T cell transfer.
Takahashi M, Watanabe S, Suzuki R, Arita M, Sato K, Sato M, Sekiya Y, Abe Y, Fujisaki T, Ohtsubo A, Shoji S, Nozaki K, Ichikawa K, Kondo R, Saida Y, Hokari S, Aoki N, Hayashi M, Ohshima Y, [...] Kikuchi T
Cancer Immunol Immunother, 71(6):1357-1369, 17 Oct 2021
Cited by: 1 article | PMID: 34657194 | PMCID: PMC10991227
Add to export list Free full text in Europe PMC
Immune Equilibrium Depends on the Interaction Between Recognition and Presentation Landscapes.
Shevyrev D, Tereshchenko V, Kozlov V
Front Immunol, 12:706136, 30 Jul 2021
Cited by: 10 articles | PMID: 34394106 | PMCID: PMC8362327
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Long-term T cell fitness and proliferation is driven by AMPK-dependent regulation of reactive oxygen species.
Lepez A, Pirnay T, Denanglaire S, Perez-Morga D, Vermeersch M, Leo O, Andris F
Sci Rep, 10(1):21673, 10 Dec 2020
Cited by: 14 articles | PMID: 33303820 | PMCID: PMC7728748
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Neurotoxicity and Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy: Insights Into Mechanisms and Novel Therapies.
Siegler EL, Kenderian SS
Front Immunol, 11:1973, 28 Aug 2020
Cited by: 110 articles | PMID: 32983132 | PMCID: PMC7485001
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Generation of bone marrow chimeras using X-ray irradiation: comparison to cesium irradiation and use in immunotherapy.
Eng J, Orf J, Perez K, Sawant D, DeVoss J
J Biol Methods, 7(1):e125, 17 Feb 2020
Cited by: 4 articles | PMID: 32206674 | PMCID: PMC7082502
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Chimeric antigen receptor T cell therapy comes to clinical practice.
Wall DA, Krueger J
Curr Oncol, 27(suppl 2):S115-S123, 01 Apr 2020
Cited by: 15 articles | PMID: 32368181 | PMCID: PMC7193999
Add to export list Review Free full text in Europe PMC
The Goldilocks Window of Personalized Chemotherapy: Getting the Immune Response Just Right.
Park DS, Robertson-Tessi M, Luddy KA, Maini PK, Bonsall MB, Gatenby RA, Anderson ARA
Cancer Res, 79(20):5302-5315, 06 Aug 2019
Cited by: 20 articles | PMID: 31387920 | PMCID: PMC6801094
Add to export list Free full text in Europe PMC
Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy.
Mahadeo KM, Khazal SJ, Abdel-Azim H, Fitzgerald JC, Taraseviciute A, Bollard CM, Tewari P, Duncan C, Traube C, McCall D, Steiner ME, Cheifetz IM, Lehmann LE, Mejia R, Slopis JM, Bajwa R, Kebriaei P, Martin PL, Moffet J, [...] Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network
Nat Rev Clin Oncol, 16(1):45-63, 01 Jan 2019
Cited by: 102 articles | PMID: 30082906 | PMCID: PMC7096894
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The expression of MHC class II molecules on murine breast tumors delays T-cell exhaustion, expands the T-cell repertoire, and slows tumor growth.
McCaw TR, Li M, Starenki D, Cooper SJ, Liu M, Meza-Perez S, Arend RC, Buchsbaum DJ, Forero A, Randall TD
Cancer Immunol Immunother, 68(2):175-188, 17 Oct 2018
Cited by: 24 articles | PMID: 30334128 | PMCID: PMC6504180
Add to export list Free full text in Europe PMC
Defining success with cellular therapeutics: the current landscape for clinical end point and toxicity analysis.
Kean LS
Blood, 131(24):2630-2639, 04 May 2018
Cited by: 5 articles | PMID: 29728399 | PMCID: PMC6032897
Add to export list Review Free full text in Europe PMC
The Cholinergic System Modulates Memory and Hippocampal Plasticity via Its Interactions with Non-Neuronal Cells.
Maurer SV, Williams CL
Front Immunol, 8:1489, 08 Nov 2017
Cited by: 109 articles | PMID: 29167670 | PMCID: PMC5682336
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The immune checkpoint protein PD-L1 induces and maintains regulatory T cells in glioblastoma.
DiDomenico J, Lamano JB, Oyon D, Li Y, Veliceasa D, Kaur G, Ampie L, Choy W, Lamano JB, Bloch O
Oncoimmunology, 7(7):e1448329, 25 Apr 2018
Cited by: 65 articles | PMID: 29900065 | PMCID: PMC5993506
Add to export list Free full text in Europe PMC
CX3CR1 identifies PD-1 therapy-responsive CD8+ T cells that withstand chemotherapy during cancer chemoimmunotherapy.
Yan Y, Cao S, Liu X, Harrington SM, Bindeman WE, Adjei AA, Jang JS, Jen J, Li Y, Chanana P, Mansfield AS, Park SS, Markovic SN, Dronca RS, Dong H
JCI Insight, 3(8):97828, 19 Apr 2018
Cited by: 79 articles | PMID: 29669928 | PMCID: PMC5931117
Add to export list Free full text in Europe PMC
Absolute lymphocyte counts at end of induction correlate with distinct immune cell compartments in pediatric B cell precursor acute lymphoblastic leukemia.
Rolf N, Smolen KK, Kariminia A, Velenosi A, Fidanza M, Strahlendorf C, Seif AE, Reid GSD
Cancer Immunol Immunother, 67(2):225-236, 20 Oct 2017
Cited by: 2 articles | PMID: 29052781 | PMCID: PMC11028201
Add to export list Free full text in Europe PMC
Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma.
Thomas AA, Abrey LE, Terziev R, Raizer J, Martinez NL, Forsyth P, Paleologos N, Matasar M, Sauter CS, Moskowitz C, Nimer SD, DeAngelis LM, Kaley T, Grimm S, Louis DN, Cairncross JG, Panageas KS, Briggs S, Faivre G, [...] Omuro A
Neuro Oncol, 19(10):1380-1390, 01 Oct 2017
Cited by: 18 articles | PMID: 28472509 | PMCID: PMC5596171
Add to export list Free full text in Europe PMC
Transfer of in vitro-expanded naïve T cells after lymphodepletion enhances antitumor immunity through the induction of polyclonal antitumor effector T cells.
Tanaka T, Watanabe S, Takahashi M, Sato K, Saida Y, Baba J, Arita M, Sato M, Ohtsubo A, Shoji S, Nozaki K, Ichikawa K, Kondo R, Aoki N, Ohshima Y, Sakagami T, Abe T, Moro H, Koya T, [...] Kikuchi T
PLoS One, 12(8):e0183976, 30 Aug 2017
Cited by: 1 article | PMID: 28854279 | PMCID: PMC5576657
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
History and current state of immunotherapy in glioma and brain metastasis.
McGranahan T, Li G, Nagpal S
Ther Adv Med Oncol, 9(5):347-368, 01 Feb 2017
Cited by: 34 articles | PMID: 28529551 | PMCID: PMC5424864
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Overcoming barriers of car T-cell therapy in patients with mesothelin-expressing cancers.
O'Hara MH, Stashwick C, Plesa G, Tanyi JL
Immunotherapy, 9(9):767-780, 03 Aug 2017
Cited by: 9 articles | PMID: 28771103
Add to export list Review
Targeting macrophage anti-tumor activity to suppress melanoma progression.
Wang H, Zhang L, Yang L, Liu C, Zhang Q, Zhang L
Oncotarget, 8(11):18486-18496, 01 Mar 2017
Cited by: 14 articles | PMID: 28060744 | PMCID: PMC5392344
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

1-25 of 201 results

1 2 3 Next ...

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

IL-2-free tumor-infiltrating lymphocyte therapy with PD-1 blockade demonstrates potent efficacy in advanced gynecologic cancer.

Mathematical modeling of endogenous and exogenously administered T cell recirculation in mouse and its application to pharmacokinetic studies of cell therapies.

How I treat cytopenias after CAR T-cell therapy.

Lymphopenia and Mechanisms of T-Cell Regeneration.

Clinical Strategies for Enhancing the Efficacy of CAR T-Cell Therapy for Hematological Malignancies.

Agent-based computational modeling of glioblastoma predicts that stromal density is central to oncolytic virus efficacy.

PD-1 blockade therapy augments the antitumor effects of lymphodepletion and adoptive T cell transfer.

Immune Equilibrium Depends on the Interaction Between Recognition and Presentation Landscapes.

Long-term T cell fitness and proliferation is driven by AMPK-dependent regulation of reactive oxygen species.

Neurotoxicity and Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy: Insights Into Mechanisms and Novel Therapies.

Generation of bone marrow chimeras using X-ray irradiation: comparison to cesium irradiation and use in immunotherapy.

Chimeric antigen receptor T cell therapy comes to clinical practice.

The Goldilocks Window of Personalized Chemotherapy: Getting the Immune Response Just Right.

Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy.

The expression of MHC class II molecules on murine breast tumors delays T-cell exhaustion, expands the T-cell repertoire, and slows tumor growth.

Defining success with cellular therapeutics: the current landscape for clinical end point and toxicity analysis.

The Cholinergic System Modulates Memory and Hippocampal Plasticity via Its Interactions with Non-Neuronal Cells.

The immune checkpoint protein PD-L1 induces and maintains regulatory T cells in glioblastoma.

CX3CR1 identifies PD-1 therapy-responsive CD8+ T cells that withstand chemotherapy during cancer chemoimmunotherapy.

Absolute lymphocyte counts at end of induction correlate with distinct immune cell compartments in pediatric B cell precursor acute lymphoblastic leukemia.

Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma.

Transfer of in vitro-expanded naïve T cells after lymphodepletion enhances antitumor immunity through the induction of polyclonal antitumor effector T cells.

History and current state of immunotherapy in glioma and brain metastasis.

Overcoming barriers of car T-cell therapy in patients with mesothelin-expressing cancers.

Targeting macrophage anti-tumor activity to suppress melanoma progression.

Partnerships & funding